News

GEN - Genetic Engineering and Biotechnology News16h
In a First, Mitochondrial Mutation Tied to Melanoma Checkpoint Resistance
Mitochondrial DNA emerges as a key factor in melanoma checkpoint inhibitor resistance, revealing new potential biomarker for patients.
Arvinas to Present Preclinical Data for PROTAC BCL6 Degrader, ARV-393, at the 2025 European Hematology Association (EHA) Annual Meeting
Company to showcase preclinical studies of ARV-393, an investigational oral PROTAC BCL6 degrader, as a single agent in models ...
MedPage Today on MSN3d
Adding Neoadjuvant Nivolumab to Chemo Improved Survival in Resectable NSCLC
Neoadjuvant nivolumab (Opdivo) plus chemotherapy significantly improved overall survival (OS) compared with chemotherapy ...
UroToday4d
ASCO 2025: Discussion: From Established Therapies to Emerging Innovations in Renal Cell Carcinoma: Checkpoints, Oxygen, and T Cells
(UroToday.com) The 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, held in Chicago, IL, was host to a kidney and bladder cancers oral abstract session. Dr. Tian Zhang discussed the ...